Media & Press Releases

ISPE announced its 2020 ISPE Europe Annual Conference, taking place virtually 15–16 September 2020, will feature a diverse mix of global health authorities providing insights COVID-19. Twenty regulatory experts representing ten countries will share...

ISPE announced the release of its latest guide, I SPE Good Practice Guide: Critical Utilities GMP Compliance – How to Be Compliant and Ready to Prove It. The Guide was cultivated by leading experts to help pharmaceutical organizations achieve and...

ISPE has been honored as the winner of a 2020 APEX Award for Publication Excellence in the Technical & Technology Writing category for the Pharmaceutical Engineering® magazine article Blockchain for Pharmaceutical Engineers. The APEX Awards recognize...

ISPE and the University of St.Gallen, Switzerland, announced today that they had signed a Memorandum of Understanding (MOU) to collaborate on tools designed to advance the state of pharmaceutical quality. ISPE’s Advancing Pharmaceutical Quality (APQ)...

ISPE announced today the formation of the new Eurasian Economic Union (Eurasia) Affiliate. The Affiliate will provide a local forum through which professionals in Russia, Armenia, Belarus, Kazakhstan, and Kyrgyzstan can contribute to the advancement...

ISPE announced that Thomas B. Hartman has been appointed as CEO & President, effective 1 June 2020. Tom has a long history of success in the pharmaceutical industry, rising to the role of Vice President of GMP Operations, Biopharm CMC, for...

ISPE announced featured presenters representing the Food and Drug Administration (FDA) at the 2020 ISPE Biopharmaceutical Manufacturing Virtual Conference. Taking place 1–2 June 2020, this first of its kind fully interactive digital event features...

ISPE announced today the 2020 Facility of the Year Awards (FOYA) Category Winners—including two winners of the inaugural Social Impact Category Award. Awardees include: F. Hoffmann-La Roche Ltd ( Equipment Innovation) Pfizer, Inc. ( Facility...

ISPE announced today that it has named Jean-François Duliere as a European Regulatory Advisor. Effective 1 April 2020, Duliere takes on this role at ISPE with extensive experience in pharmaceutical regulatory compliance and facilities design for...

ISPE announced Wilson Bryan, MD, Director, Office of Tissues and Advanced Therapies, FDA, as a newly confirmed keynote for the 2020 ISPE Biopharmaceutical Manufacturing Conference, taking place 1–3 June 2020 in Boston, Massachusetts. Wilson Bryan is...